Skip to main content
Top
Published in: Clinical Rheumatology 7/2008

01-07-2008 | Original Article

Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients

Authors: Servet Akar, Gercek Can, Omer Binicier, Kenan Aksu, Baris Akinci, Dilek Solmaz, Merih Birlik, Gökhan Keser, Nurullah Akkoc, Fatos Onen

Published in: Clinical Rheumatology | Issue 7/2008

Login to get access

Abstract

The aims of the study were to assess the health-related quality of life (QOL) in patients with Takayasu's arteritis (TA) by two different generic QOL instruments and to compare the results with those patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and healthy controls (HC). A cross-sectional study was performed in 51 patients with TA (41 women; mean age 38.4 ± 13.5), 43 RA (36 women; 55.2 ± 9.6), 31 AS (12 women; 41.2 ± 13.1), and 75 HC (53 women; 38.8 ± 10.9). Quality of life was assessed by using Short-Form 36 (SF-36) and Nottingham Health Profile (NHP). Separate dimensions of SF-36 and NHP and physical and mental summary scores of SF-36 as well were compared between patients and control groups. Physical and mental health summary scores and all SF-36 subscales, except for social functioning, were significantly lower in patients with TA than healthy controls. No significant differences between TA, RA, and AS patients were found in all SF-36 subscales and summary scores. NHP scores for energy level, pain, emotional reactions, and physical mobility were significantly higher in TA patients than controls. All NHP subscales, except for pain, were comparable in patients with TA, RA, and AS. Pain score was worse in RA patients. The NHP scores for sleep and social isolation were not different between patients and controls. Many aspects of QOL in patients with TA are significantly impaired in comparison with local healthy controls and similar to those in patients with RA and AS.
Literature
1.
go back to reference Andrews J, Mason JC (2007) Takayasu's arteritis—recent advances in imaging offer promise. Rheumatology (Oxford) 46(1):6–15 JanCrossRef Andrews J, Mason JC (2007) Takayasu's arteritis—recent advances in imaging offer promise. Rheumatology (Oxford) 46(1):6–15 JanCrossRef
2.
go back to reference Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M et al (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929 Jun 1PubMed Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M et al (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929 Jun 1PubMed
3.
go back to reference Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE (1977) Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 93(1):94–103 JanPubMedCrossRef Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE (1977) Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 93(1):94–103 JanPubMedCrossRef
4.
go back to reference Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA et al (2005) Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg 75(3):110–117 MarPubMedCrossRef Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA et al (2005) Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg 75(3):110–117 MarPubMedCrossRef
5.
go back to reference Subramanyan R, Joy J, Balakrishnan KG (1989) Natural history of aortoarteritis (Takayasu's disease). Circulation 80(3):429–437 SepPubMed Subramanyan R, Joy J, Balakrishnan KG (1989) Natural history of aortoarteritis (Takayasu's disease). Circulation 80(3):429–437 SepPubMed
6.
go back to reference Essink-Bot ML, Krabbe PF, Bonsel GJ, Aaronson NK (1997) An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument. Med Care 35(5):522–537 MayPubMedCrossRef Essink-Bot ML, Krabbe PF, Bonsel GJ, Aaronson NK (1997) An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument. Med Care 35(5):522–537 MayPubMedCrossRef
7.
go back to reference Ward MM (2004) Outcome measurement: health status and quality of life. Curr Opin Rheumatol 16(2):96–101 MarPubMedCrossRef Ward MM (2004) Outcome measurement: health status and quality of life. Curr Opin Rheumatol 16(2):96–101 MarPubMedCrossRef
8.
9.
go back to reference Coons SJ, Rao S, Keininger DL, Hays RD (2000) A comparative review of generic quality-of-life instruments. Pharmacoeconomics 17(1):13–35 JanPubMedCrossRef Coons SJ, Rao S, Keininger DL, Hays RD (2000) A comparative review of generic quality-of-life instruments. Pharmacoeconomics 17(1):13–35 JanPubMedCrossRef
10.
go back to reference Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Med Care 27(3 Suppl):S217–S232 MarPubMedCrossRef Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Med Care 27(3 Suppl):S217–S232 MarPubMedCrossRef
11.
go back to reference Hellmann DB, Uhlfelder ML, Stone JH, Jenckes MW, Cid MC, Guillevin L et al (2003) Domains of health-related quality of life important to patients with giant cell arteritis. Arthritis Rheum 49(6):819–825 Dec 15PubMedCrossRef Hellmann DB, Uhlfelder ML, Stone JH, Jenckes MW, Cid MC, Guillevin L et al (2003) Domains of health-related quality of life important to patients with giant cell arteritis. Arthritis Rheum 49(6):819–825 Dec 15PubMedCrossRef
12.
go back to reference Hoffman GS, Drucker Y, Cotch MF, Locker GA, Easley K, Kwoh K (1998) Wegener's granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum 41(12):2257–2262 DecPubMedCrossRef Hoffman GS, Drucker Y, Cotch MF, Locker GA, Easley K, Kwoh K (1998) Wegener's granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum 41(12):2257–2262 DecPubMedCrossRef
13.
go back to reference Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DG (2003) Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 49(6):826–378 Dec 15PubMedCrossRef Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DG (2003) Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 49(6):826–378 Dec 15PubMedCrossRef
14.
go back to reference Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gutfleisch J, Peter HH, Raspe HH et al (2002) Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum 47(3):320–325 Jun 15PubMedCrossRef Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gutfleisch J, Peter HH, Raspe HH et al (2002) Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum 47(3):320–325 Jun 15PubMedCrossRef
15.
go back to reference Stewart AL, Sherbourne CD, Hays RD et al (1992) Summary and discussion of MOS measures. In: Stewart AL, Ware JE (eds) Measuring functioning and well-being: the medical outcomes study approach. Duke University Press, Durham (NC), pp 345–371 Stewart AL, Sherbourne CD, Hays RD et al (1992) Summary and discussion of MOS measures. In: Stewart AL, Ware JE (eds) Measuring functioning and well-being: the medical outcomes study approach. Duke University Press, Durham (NC), pp 345–371
16.
go back to reference McEwen JE, McKenna SP (1996) Nottingham health profile. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials. 2nd edn. Lippincott-Raven, Philadelphia, pp 281–286 McEwen JE, McKenna SP (1996) Nottingham health profile. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials. 2nd edn. Lippincott-Raven, Philadelphia, pp 281–286
17.
go back to reference Bostan EE, Borman P, Bodur H, Barca N (2003) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 23(3):121–126 MayPubMed Bostan EE, Borman P, Bodur H, Barca N (2003) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 23(3):121–126 MayPubMed
18.
go back to reference Chorus AM, Miedema HS, Boonen A, Van Der Linden S (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62(12):1178–1184 DecPubMedCrossRef Chorus AM, Miedema HS, Boonen A, Van Der Linden S (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62(12):1178–1184 DecPubMedCrossRef
19.
go back to reference Houssien DA, McKenna SP, Scott DL (1997) The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis. Br J Rheumatol 36(1):69–73 JanPubMedCrossRef Houssien DA, McKenna SP, Scott DL (1997) The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis. Br J Rheumatol 36(1):69–73 JanPubMedCrossRef
20.
go back to reference Sivas F, Ercin O, Tanyolac O, Barca N, Aydog S, Ozoran K (2004) The Nottingham Health Profile in rheumatoid arthritis: correlation with other health status measurements and clinical variables. Rheumatol Int 24(4):203–206 JulPubMedCrossRef Sivas F, Ercin O, Tanyolac O, Barca N, Aydog S, Ozoran K (2004) The Nottingham Health Profile in rheumatoid arthritis: correlation with other health status measurements and clinical variables. Rheumatol Int 24(4):203–206 JulPubMedCrossRef
21.
go back to reference Srouji IA, Andrews P, Edwards C, Lund VJ (2006) General and rhinosinusitis-related quality of life in patients with Wegener's granulomatosis. Laryngoscope 116(9):1621–1625 SepPubMedCrossRef Srouji IA, Andrews P, Edwards C, Lund VJ (2006) General and rhinosinusitis-related quality of life in patients with Wegener's granulomatosis. Laryngoscope 116(9):1621–1625 SepPubMedCrossRef
22.
go back to reference Pinar R (2005) Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res 14(1):259–642 FebPubMedCrossRef Pinar R (2005) Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res 14(1):259–642 FebPubMedCrossRef
23.
go back to reference Kucukdeveci AA, McKenna SP, Kutlay S, Gursel Y, Whalley D, Arasil T (2000) The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 23(1):31–38 MarPubMedCrossRef Kucukdeveci AA, McKenna SP, Kutlay S, Gursel Y, Whalley D, Arasil T (2000) The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 23(1):31–38 MarPubMedCrossRef
24.
go back to reference Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134 AugPubMedCrossRef Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134 AugPubMedCrossRef
25.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1998) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324 MarCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1998) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324 MarCrossRef
26.
go back to reference van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368 AprPubMedCrossRef van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368 AprPubMedCrossRef
27.
go back to reference Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48 JanPubMedCrossRef Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48 JanPubMedCrossRef
28.
go back to reference Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23(2):137–145 FebPubMedCrossRef Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23(2):137–145 FebPubMedCrossRef
29.
go back to reference Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 38(9):878–882 SepCrossRef Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M (1999) Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology (Oxford) 38(9):878–882 SepCrossRef
30.
go back to reference Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21(12):2281–2285 DecPubMed Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21(12):2281–2285 DecPubMed
31.
go back to reference Sprangers MA, de Regt EB, Andries F, van Agt HM, Bijl RV, de Boer JB et al (2000) Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol 53(9):895–907 SepPubMedCrossRef Sprangers MA, de Regt EB, Andries F, van Agt HM, Bijl RV, de Boer JB et al (2000) Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol 53(9):895–907 SepPubMedCrossRef
32.
go back to reference Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 33(4 Suppl):AS264–AS279 AprPubMed Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 33(4 Suppl):AS264–AS279 AprPubMed
33.
go back to reference Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54 Suppl:S155–S163 AugPubMedCrossRef Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54 Suppl:S155–S163 AugPubMedCrossRef
34.
go back to reference Gamba S, Cicci L, Stefanov R (2003) Quality of life in patients with unusual diseases: experience of nurses at the clinical research center for unusual diseases Aldo e Cele Dacco. Assist Inferm Ric 22(3):144–150 Jul–SepPubMed Gamba S, Cicci L, Stefanov R (2003) Quality of life in patients with unusual diseases: experience of nurses at the clinical research center for unusual diseases Aldo e Cele Dacco. Assist Inferm Ric 22(3):144–150 Jul–SepPubMed
35.
go back to reference Hoffman GS, Ahmed AE (1998) Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 66(Suppl 1):S191–S194 discussion S5, Oct 1PubMedCrossRef Hoffman GS, Ahmed AE (1998) Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 66(Suppl 1):S191–S194 discussion S5, Oct 1PubMedCrossRef
36.
go back to reference Lagneau P, Michel JB, Vuong PN (1987) Surgical treatment of Takayasu's disease. Ann Surg 205(2):157–166 FebPubMedCrossRef Lagneau P, Michel JB, Vuong PN (1987) Surgical treatment of Takayasu's disease. Ann Surg 205(2):157–166 FebPubMedCrossRef
37.
go back to reference Burckhardt CS, Clark SR, Bennett RM (1993) Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 20(3):475–479 MarPubMed Burckhardt CS, Clark SR, Bennett RM (1993) Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 20(3):475–479 MarPubMed
38.
go back to reference Drent M, Wirnsberger RM, Breteler MH, Kock LM, de Vries J, Wouters EF (1998) Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 15(1):59–66 MarPubMed Drent M, Wirnsberger RM, Breteler MH, Kock LM, de Vries J, Wouters EF (1998) Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 15(1):59–66 MarPubMed
39.
go back to reference Zink A, Braun J, Listing J, Wollenhaupt J (2000) Disability and handicap in rheumatoid arthritis and ankylosing spondylitis—results from the German rheumatological database. German collaborative arthritis centers. J Rheumatol 27(3):613–622 MarPubMed Zink A, Braun J, Listing J, Wollenhaupt J (2000) Disability and handicap in rheumatoid arthritis and ankylosing spondylitis—results from the German rheumatological database. German collaborative arthritis centers. J Rheumatol 27(3):613–622 MarPubMed
40.
go back to reference Kutlay S, Nergizoglu G, Kutlay S, Keven K, Erturk S, Ates K et al (2003) General or disease specific questionnaire? A comparative study in hemodialysis patients. Ren Fail 25(1):95–103 JanPubMedCrossRef Kutlay S, Nergizoglu G, Kutlay S, Keven K, Erturk S, Ates K et al (2003) General or disease specific questionnaire? A comparative study in hemodialysis patients. Ren Fail 25(1):95–103 JanPubMedCrossRef
41.
go back to reference Uutela T, Hakala M, Kautiainen H (2003) Validity of the Nottingham Health Profile in a Finnish out-patient population with rheumatoid arthritis. Rheumatology (Oxford) 42(7):841–845 JulCrossRef Uutela T, Hakala M, Kautiainen H (2003) Validity of the Nottingham Health Profile in a Finnish out-patient population with rheumatoid arthritis. Rheumatology (Oxford) 42(7):841–845 JulCrossRef
43.
go back to reference Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A, Mowat A (1992) A generic health status instrument in the assessment of rheumatoid arthritis. Br J Rheumatol 31(2):87–90 FebPubMedCrossRef Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A, Mowat A (1992) A generic health status instrument in the assessment of rheumatoid arthritis. Br J Rheumatol 31(2):87–90 FebPubMedCrossRef
Metadata
Title
Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients
Authors
Servet Akar
Gercek Can
Omer Binicier
Kenan Aksu
Baris Akinci
Dilek Solmaz
Merih Birlik
Gökhan Keser
Nurullah Akkoc
Fatos Onen
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 7/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0813-9

Other articles of this Issue 7/2008

Clinical Rheumatology 7/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine